ketamine has been researched along with Myelopathy in 10 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This 60-year-old man with cervical spondylosis experienced bilateral arm pain and weakness." | 5.36 | [Ketamine treatment for severe neuropathic pain with cervical spondylotic myelopathy. A case report]. ( Hamauchi, S; Isobe, M; Isu, T; Kim, K; Kyongsong, K; Matsumoto, R; Morimoto, D; Shimoda, Y, 2010) |
| "This 60-year-old man with cervical spondylosis experienced bilateral arm pain and weakness." | 1.36 | [Ketamine treatment for severe neuropathic pain with cervical spondylotic myelopathy. A case report]. ( Hamauchi, S; Isobe, M; Isu, T; Kim, K; Kyongsong, K; Matsumoto, R; Morimoto, D; Shimoda, Y, 2010) |
| "The authors conclude that repeated intrathecal administration of preservative-free S(+)-ketamine in a clinically relevant concentration and dosage has, considering the extent and severity of the lesions, a toxic effect on the central nervous system of rabbits." | 1.33 | Severe toxic damage to the rabbit spinal cord after intrathecal administration of preservative-free S(+)-ketamine. ( de Haan, P; Dijkgraaf, MG; Hollmann, MW; Pennings, FA; Troost, D; van der Vegt, MH; Vranken, JH, 2006) |
| " The rationale for this treatment, along with dosing guidelines and possible drawbacks, is discussed." | 1.32 | Ketamine patient-controlled analgesia for dysesthetic central pain. ( Cohen, SP; DeJesus, M, 2004) |
| "Ketamine has been reported to have little effect on MEPs but may produce adverse effects such as psychedelic effect and hypertension." | 1.31 | Low dose propofol as a supplement to ketamine-based anesthesia during intraoperative monitoring of motor-evoked potentials. ( Furuya, H; Inoue, S; Kakimoto, M; Kawaguchi, M; Morimoto, T; Sakaki, T; Sakamoto, T, 2000) |
| "Ketamine is an injectable anesthetic induction agent that has been reported to have analgesic activity in pain from a variety of mechanisms, but predominantly in neuralgic and dysesthetic neuropathic pain." | 1.30 | Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report. ( Fisher, K; Hagen, NA, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamauchi, S | 1 |
| Kim, K | 1 |
| Kyongsong, K | 1 |
| Morimoto, D | 1 |
| Isu, T | 1 |
| Shimoda, Y | 1 |
| Matsumoto, R | 1 |
| Isobe, M | 1 |
| Cohen, SP | 1 |
| DeJesus, M | 1 |
| Prommer, E | 1 |
| Vranken, JH | 1 |
| Troost, D | 1 |
| de Haan, P | 2 |
| Pennings, FA | 1 |
| van der Vegt, MH | 1 |
| Dijkgraaf, MG | 1 |
| Hollmann, MW | 1 |
| Malinovsky, JM | 1 |
| Lepage, JY | 1 |
| Cozian, A | 1 |
| Mussini, JM | 1 |
| Pinaudt, M | 1 |
| Souron, R | 1 |
| Karpinski, N | 1 |
| Dunn, J | 1 |
| Hansen, L | 1 |
| Masliah, E | 1 |
| Kalkman, CJ | 1 |
| Vanicky, I | 1 |
| Jacobs, MJ | 1 |
| Drummond, JC | 1 |
| Fisher, K | 1 |
| Hagen, NA | 1 |
| Errando, CL | 1 |
| Kawaguchi, M | 1 |
| Sakamoto, T | 1 |
| Inoue, S | 1 |
| Kakimoto, M | 1 |
| Furuya, H | 1 |
| Morimoto, T | 1 |
| Sakaki, T | 1 |
10 other studies available for ketamine and Myelopathy
| Article | Year |
|---|---|
[Ketamine treatment for severe neuropathic pain with cervical spondylotic myelopathy. A case report].
Topics: Humans; Ketamine; Male; Middle Aged; Neuralgia; Spinal Cord Diseases; Spondylosis | 2010 |
Ketamine patient-controlled analgesia for dysesthetic central pain.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics; Female; Humans; Infusions, Intravenous; Ketamine; | 2004 |
Ketamine and HTLV-1 myelopathy: NMDA blockade and immunomodulation?
Topics: Excitatory Amino Acid Antagonists; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunolo | 2006 |
Severe toxic damage to the rabbit spinal cord after intrathecal administration of preservative-free S(+)-ketamine.
Topics: Anesthesia, Spinal; Anesthetics, Dissociative; Animals; Excitatory Amino Acid Antagonists; Female; I | 2006 |
Is ketamine or its preservative responsible for neurotoxicity in the rabbit?
Topics: Animals; Chlorobutanol; Injections, Spinal; Ketamine; Preservatives, Pharmaceutical; Rabbits; Spinal | 1993 |
Subpial vacuolar myelopathy after intrathecal ketamine: report of a case.
Topics: Anesthetics, Intravenous; Carcinoid Tumor; Chronic Disease; Fatal Outcome; Humans; Injections, Spina | 1997 |
Effect of mild hypothermia and the 21-aminosteroid U-74389G on neurologic and histopathologic outcome after transient spinal cord ischemia in the rabbit.
Topics: Anesthesia, Intravenous; Anesthetics, Intravenous; Animals; Blood Gas Analysis; Body Temperature; Bo | 1998 |
Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report.
Topics: Administration, Oral; Adult; Analgesics; Chronic Disease; Humans; Ketamine; Male; Neuralgia; Spinal | 1999 |
Spinal toxicity of drugs: some specifications about ketamine.
Topics: Anesthetics, Dissociative; Animals; Injections, Spinal; Ketamine; Spinal Cord Diseases; Swine | 2000 |
Low dose propofol as a supplement to ketamine-based anesthesia during intraoperative monitoring of motor-evoked potentials.
Topics: Adolescent; Adult; Anesthesia, Intravenous; Anesthetics, Dissociative; Anesthetics, Intravenous; Bra | 2000 |